Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease
NCT02770430
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Graft vs Host Disease
Interventions
BIOLOGICAL:
mesenchymal stem cells
DRUG:
conventional treatment
Sponsor
Hospital de Clinicas de Porto Alegre